FlaggedRx← Medication recall checkHome
Class II · ModerateActive recall

Lorazepam

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot # K24118, exp. date 10/31/2026
Where it was soldDistributed Nationwide in the USA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byHikma Berkeley Heights, NJ 07922
Brand nameLORAZEPAM
Generic nameLORAZEPAM
Active ingredient(s)LORAZEPAM
Distributed by / forHikma Pharmaceuticals USA Inc.
NDC0641-6044-25
Show the full FDA record
Full product labelLorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Recalling firmHikma Pharmaceuticals USA Inc.
DistributionDistributed Nationwide in the USA
Quantity382,775 1mL vials
Recall initiated2025-07-22
Report date2025-08-06
Recall completed—
Recall numberD-0551-2025
ClassificationClass II
FDA statusOngoing
Origin on fileCherry Hill NJ United States

Related

Recent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.